Advertisement

Factors influencing the results of surgical therapy of non-acute subdural haematomas

  • Opšenák René
  • Hanko Martin
  • Snopko Pavol
  • Varga Kristián
  • Fejerčák Tomáš
  • Kolarovszki BranislavEmail author
Original Article
  • 2 Downloads

Abstract

Purpose

To identify predictive factors with an impact on the outcome of surgical treatment of non-acute subdural haematomas (NASH).

Methods

One hundred eleven patients who underwent an evacuation of 132 NASH by means of burr hole or craniotomy from January 2014 to December 2018 were retrospectively analyzed. We evaluated the impact of factors that could possibly predict the result of surgical treatment. The assessment was focused on the impact of factors, such as age, gender, pre-operative clinical symptoms, timing and extent of surgical procedure, intake of anticoagulants and antiplatelet drugs, morphological type, recurrence, side localization or bilateral occurrence of NASH. Patients’ functional outcome was quantified using the Glasgow Outcome Score (GOS) with a follow-up period of 3 months.

Results

Morphological type of NASH did not have any significant impact on the final GOS. The risk factors associated with less favorable GOS included preoperative intake of anticoagulants and preoperative finding of phatic disorder, quantitative disorder of consciousness and disorientation. Preoperative intake of antiplatelet drugs or anticoagulants and craniotomy were risk factors for postoperative development of a surgically significant acute extracerebral haematoma. The complications occurred significantly more often after a craniotomy when compared to the burr hole evacuation (p = 0.0163), but the incidence of recurrence of NASH was significantly lower (p = 0.0439).

Conclusion

The risk factors for the surgical treatment of NASH included preoperative intake of antithrombotic drugs and evacuation of NASH through craniotomy. Craniotomy resulted in a significantly lower incidence of recurrence.

Keywords

Subdural haematoma Outcome Risk factors Recurrence 

Notes

Acknowledgements

This work was supported by project named The application of PACS (Picture Archiving and Communication System) in research and development, ITMS 26,210,120,004. All authors agree to the publication of this article.

Compliance with ethical standards

Conflict of interest

Authors hereby certify that they have no conflicts of interest to declare in connection with this study.

References

  1. 1.
    Santarius T, Kirkpatrick PJ, Kolias AG, et al. Working toward rational and evidence-based treatment of chronic subdural hematoma. Clin Neurosurg. 2010;57:112–22.PubMedGoogle Scholar
  2. 2.
    Ducruet AF, Grobelny BT, Zacharia BE, et al. The surgical management of chronic subdural hematoma. Neurosurg Rev. 2012;35(2):155–69.  https://doi.org/10.1007/s10143-011-0349-y.CrossRefPubMedGoogle Scholar
  3. 3.
    Markwalder TM. Chronic subdural hematomas: a review. J Neurosurg. 1981;54(5):637–45.  https://doi.org/10.3171/jns.1981.54.5.0637.CrossRefPubMedGoogle Scholar
  4. 4.
    Murakami H, Hirose Y, Sagoh M, et al. Why do chronic subdural hematomas continue to grow slowly and not coagulate? Role of trombomodulin in the mechanism. J Neurosurg. 2002;96(5):877–84.  https://doi.org/10.3171/jns.2002.96.5.0877.CrossRefPubMedGoogle Scholar
  5. 5.
    Weigel R, Schilling L, Schmiedek P. Specific pattern of growth factor distribution in chronic subdural hematoma (CSH): evidence for an angiogenic disease. Acta Neurochir (Wien). 2001;143(8):811–8.CrossRefGoogle Scholar
  6. 6.
    Nakaguchi H, Tanishima T, Yoshimasu N. Factors in the natural history of chronic subdural hematomas that influence their postoperative recurrence. J Neurosurg. 2001;95(2):256–62.  https://doi.org/10.3171/jns.2001.95.2.0256.CrossRefPubMedGoogle Scholar
  7. 7.
    Jennet B, Snoek J, Bond MR, et al. Disability after severe head injury: observations on the use of the Glasgow Outcome Scale. J Neurol Neurosurg Psychiatry. 1981;44(4):285–93.CrossRefGoogle Scholar
  8. 8.
    Ro HW, Park SK, Jang DK, et al. Preoperative predictive factors for surgical and functional outcomes in chronic subdural hematoma. Acta Neurochir (Wien). 2016;158(1):135–9.  https://doi.org/10.1007/s00701-015-2625-z.CrossRefPubMedGoogle Scholar
  9. 9.
    Motiei-Langroudi R, Stippler M, Shi S, et al. Factors predicting reoperation of chronic subdural hematoma following primary surgical evacuation. J Neurosurg. 2018;129(5):1143–50.  https://doi.org/10.3171/2017.6.JNS17130.CrossRefPubMedGoogle Scholar
  10. 10.
    Lee J, Park JH. Clinical characteristics of bilateral versus unilateral chronic subdural hematoma. Korean J Neurotrauma. 2014;10(2):49–544.  https://doi.org/10.13004/kjnt.2014.10.2.49.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Hsieh CT, Su IC, Hsu SK, et al. Chronic subdural hematoma: differences between unilateral and bilateral occurrence. J Clin Neurosci. 2016;34:252–8.  https://doi.org/10.1016/j.jocn.2016.09.015.CrossRefPubMedGoogle Scholar
  12. 12.
    You W, Zhu Y, Wang Y, et al. Prevalence of and risk factors for recurrence of chronic subdural hematoma. Acta Neurochir (Wien). 2018;160(5):893–9.  https://doi.org/10.1007/s00701-018-3513-0.CrossRefPubMedGoogle Scholar
  13. 13.
    Hammer A, Tregubow A, Kerry G, et al. Predictors for recurrence of chronic subdural hematoma. Turk Neurosurg. 2017;27(5):756–62.  https://doi.org/10.5137/1019-5149.JTN.17347-16.1.CrossRefPubMedGoogle Scholar
  14. 14.
    Stanisic M, Pripp AH. A reliable grading system for prediction of chronic subdural hematoma recurrence requiring reoperation after initial burr-hole surgery. Neurosurgery. 2017;81(5):752–60.  https://doi.org/10.1093/neuros/nyx090.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Altaf I, Shams S, Vohra AH. Radiolological predictors of recurrence of chronic subdural hematoma. Pak J Med Sci. 2018;34(1):194–7.  https://doi.org/10.12669/pjms.341.13735.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Wang Y, Zhou J, Fan C, et al. Influence of antithrombotic agents on the recurrence of chronic subdural hematomas and the quest about the recommencement of antithrombotic agents: a meta-analysis. J Clin Neurosci. 2017;38:79–83.  https://doi.org/10.1016/j.jocn.2016.12.001.CrossRefPubMedGoogle Scholar
  17. 17.
    Poon MTC, Al-Shahi SR. Association between antithrombotic drug use before chronic subdural haematoma and outcome after drainage: a systematic review and meta-analysis. Neurosurg Rev. 2018;41(2):439–45.  https://doi.org/10.1007/s10143-017-0860-x.CrossRefPubMedGoogle Scholar
  18. 18.
    Motoie R, Karashima S, Otsuji R, et al. Recurrence in 787 patients with chronic subdural hematoma: retrospective cohort investigation of associated factors including direct oral anticoagulant use. World Neurosurg. 2018;118:e87–e91.  https://doi.org/10.1016/j.wneu.2018.06.124.CrossRefPubMedGoogle Scholar
  19. 19.
    Scerrati A, Mangiola A, Rigoni F, et al. Do antiplatelet and anticoagulant drugs modify outcome of patients treated for chronic subdural hematoma? Still a controversial issue. J Neurosurg Sci. 2018.  https://doi.org/10.23736/S0390-5616.18.04311-4.CrossRefPubMedGoogle Scholar
  20. 20.
    Glancz LJ, Poon MTC, Coulter IC, et al. Does drain position and duration influence outcomes in patients undergoing burr-hole evacuation of chronic subdural hematoma? lessons from a UK Multicenter Prospective Cohort Study. Neurosurgery. 2018.  https://doi.org/10.1093/neuros/nyy366.CrossRefPubMedCentralGoogle Scholar
  21. 21.
    Goyal RK, Nayak B, Maharshi R, et al. Management of chronic subdural hematoma: burr hole versus twist drill—a prospective study. Asian J Neurosurg. 2018;13(2):319–23.  https://doi.org/10.4103/ajns.AJNS_99_16.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Yan C, Yang MF, Huang YW. A reliable nomogram model to predict the recurrence of chronic subdural hematoma after burr hole surgery. World Neurosurg. 2018;118:e356–e366366.  https://doi.org/10.1016/j.wneu.2018.06.191.CrossRefPubMedGoogle Scholar
  23. 23.
    You CG, Zheng XS. Postoperative pneumocephalus increases the recurrence rate of chronic subdural hematoma. Clin Neurol Neurosurg. 2018;166:56–60.  https://doi.org/10.1016/j.clineuro.2018.01.029.CrossRefPubMedGoogle Scholar
  24. 24.
    Haron S, Bogduk N, Hansen M. A retrospective analysis of chronic subdural haematoma recurrence rates following burr hole trephination versus minicraniotomy. J Clin Neurosci. 2019;59:47–50.  https://doi.org/10.1016/j.jocn.2018.11.009.CrossRefPubMedGoogle Scholar
  25. 25.
    Kocaman U, Yilmaz H. Description of a modified technique (mini craniotomy-basal membranotomy) for chronic subdural hematoma surgery and evaluation of the contribution of basal membranotomy performed as part of this technique to cerebral expansion. World Neurosurg. 2019;122:e1002–e10061006.  https://doi.org/10.1016/j.wneu.2018.10.196.CrossRefPubMedGoogle Scholar
  26. 26.
    Heringer LC, Sousa UO, Oliveira MF, et al. The number of burr holes and use of a drain do not interfere with surgical results of chronic sudbural hematomas. Arq Neuropsiquiatr. 2017;75(11):809–12.  https://doi.org/10.1590/0004-282X20170136.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Opšenák René
    • 1
  • Hanko Martin
    • 1
  • Snopko Pavol
    • 1
  • Varga Kristián
    • 1
  • Fejerčák Tomáš
    • 1
  • Kolarovszki Branislav
    • 1
    Email author
  1. 1.Clinic of Neurosurgery, Jessenius Faculty of Medicine in MartinComenius University in Bratislava, University Hospital MartinMartinSlovakia

Personalised recommendations